A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of 131I and review of the literature: implications for …
AF Leger, M Pellan, F Dagousset… - The British Journal of …, 2005 - academic.oup.com
Thyroid stunning is usually defined as the inhibition or suppression of iodide trapping by
remnant thyroid tissue or by functioning metastases following a diagnostic dose of 131I. The …
remnant thyroid tissue or by functioning metastases following a diagnostic dose of 131I. The …
[PDF][PDF] Thyroid stunning in clinical practice: is it a real problem
M Filesi, M Colandrea, T Montesano… - Minerva …, 2009 - researchgate.net
Stunning is a phenomenon of reducing 131I uptaking activity by residual or metastatic tissue
during the follow-up of patients after total thyroidectomy for differentiated thyroid carcinoma …
during the follow-up of patients after total thyroidectomy for differentiated thyroid carcinoma …
The management of differentiated thyroid cancer using 123I for imaging to assess the need for 131I therapy
N Ali, C Sebastian, RR Foley, I Murray… - Nuclear medicine …, 2006 - journals.lww.com
Background Follow-up of 131 I whole-body scanning after 131 I ablation is associated with
potential stunning. Previous studies have suggested that, for scanning, 123 I is more …
potential stunning. Previous studies have suggested that, for scanning, 123 I is more …
The comparison of 131I whole-body scans on the third and tenth day after 131I therapy in patients with well-differentiated thyroid cancer: preliminary report
JW Lee, SM Lee, GP Koh, DH Lee - Annals of nuclear medicine, 2011 - Springer
Objective The purpose of the present study was to evaluate the clinical usefulness of the
delayed post-therapeutic 131 I scan in patients with well-differentiated thyroid cancer by …
delayed post-therapeutic 131 I scan in patients with well-differentiated thyroid cancer by …
Evaluation of ablation of thyroid remnants with 1850 MBq iodine-131 in 67 patients with thyroid cancer.
J Kawabe, S Higashiyama, K Kotani… - The Quarterly Journal …, 2016 - europepmc.org
Background Radioiodine remnant ablation (RRA) is used to destroy residual normal thyroid
tissue after total thyroidectomy in differentiated thyroid carcinoma (DTC) patients. As 1850 …
tissue after total thyroidectomy in differentiated thyroid carcinoma (DTC) patients. As 1850 …
The role of 123I‐diagnostic imaging in the follow‐up of patients with differentiated thyroid carcinoma as compared to 131I‐scanning: avoidance of negative …
A Siddiqi, RR Foley, KE Britton, A Sibtain… - Clinical …, 2001 - Wiley Online Library
OBJECTIVE Some patients with relapsed differentiated thyroid cancer may show rising
thyroglobulin (Tg) levels despite a lack of 131I uptake on routine whole body imaging. A …
thyroglobulin (Tg) levels despite a lack of 131I uptake on routine whole body imaging. A …
Thyroid stunning
RJ Amdur, EL Mazzaferri - Essentials of thyroid cancer management, 2005 - Springer
First described by Rawson et al. in 1951, thyroid stunning has become a subject of
considerable controversy. Diagnostic whole body scan (DxWBS) images are usually …
considerable controversy. Diagnostic whole body scan (DxWBS) images are usually …
123I: almost a designer radioiodine for thyroid scanning
HM Park - Journal of Nuclear Medicine, 2002 - Soc Nuclear Med
The merits of 123I as a thyroid scanning agent have been lauded since it became possible
to produce 123I using a cyclotron. In 1967, Rhodes et al.(1) stated:“In the past, the …
to produce 123I using a cyclotron. In 1967, Rhodes et al.(1) stated:“In the past, the …
A clinical trial of optimal time interval between ablation and diagnostic activity when a pretherapy RAI scanning is performed on patients with differentiated thyroid …
Y Yin, Q Mao, S Chen, N Li, X Li, Y Li - Medicine, 2015 - journals.lww.com
This article investigates the association of the time interval between the diagnostic dose and
ablation with the stunning effect, when a 74 MBq 131 I pretherapy scanning was performed …
ablation with the stunning effect, when a 74 MBq 131 I pretherapy scanning was performed …
Potential adverse effect of high survey dose of I-131 administered prior to I-131 therapy in the management of differentiated thyroid carcinomas
HM Park, A Siddiqui, R Burt, D Schauwecker… - Radiologia …, 1992 - inis.iaea.org
[en] We investigated the effect of the diagnostic scanning dose of I-131 sodium iodide (111
to 370 MBq or 3 to 10 mCi) on the subsequent uptake of the therapeutic dose of I-131 by the …
to 370 MBq or 3 to 10 mCi) on the subsequent uptake of the therapeutic dose of I-131 by the …